Walgreens Boots Alliance (WBA) posted its second report, revealing a quarterly revenue that beat expectations but a narrow outlook for 2024, citing difficult conditions within the retail environment.
Walgreens' healthcare arm in the U.S. had fourth-quarter sales of $622 million, representing 34% growth on a pro forma basis. The company is raising its fiscal 2025 sales target for the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results